为期四个月的高剂量里法辛治疗肺结核的疗法
Amina Jindani1, Daniel Atwine2,3, Daniel Grint4
1Institute for Infection and Immunity, St. George's, University of London, London.
NEJM evidence
|February 6, 2024
概括
研究人员评估了使用高剂量里法匹辛的较短结核病治疗方案. 尽管可接受的安全性概况,四个月的治疗方案并未证明与肺结核的标准6个月治疗不逊色.
科学领域:
- 传染性疾病 传染性疾病
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 需要更短,有效的结核病 (TB) 治疗方案.
- 高剂量的里法西因显示出更快的肺灭菌的潜力,并使结核病治疗持续时间缩短.
研究的目的:
- 与肺结核的标准6个月疗程相比,评估4个月高剂量里法皮辛疗程的非劣势性.
- 与标准治疗方案相比,评估两种高剂量里法素 (1200 mg/d和1800 mg/d) 治疗方案的安全性和疗效.
主要方法:
- 随机对照试验涉及成年人,他们患有对利芬素敏感的肺结核病.
- 六个月的对照疗法与两个四个月的高剂量里法皮辛疗法 (SR1: 1200 mg/d,SR2: 1800 mg/d) 的比较.
- 主要终点:治疗失败和复发的复合在唾液涂抹阳性患者;非劣势率为8个百分点.
主要成果:
- 在4个月高剂量里法皮辛治疗方案中,没有证明非劣质性.
- 良好的反应率为93% (对照组),90% (SR1) 和87% (SR2).
- 三级或四级不良事件在各组之间是可比的 (4.0%对照,4.5%SR1,4.4%SR2).
结论:
- 长达四个月的高剂量里法辛治疗方案不符合肺结核治疗的非劣质性标准.
- 这些疗法表现出可接受的安全性,没有剂量限制性毒性.
- 标准的6个月疗程仍然是有效治疗肺结核的基准.
相关概念视频
01:28Pulmonary Tuberculosis V
180
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
180
01:26Pulmonary Tuberculosis IV
143
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
143
01:29Pulmonary Tuberculosis I
243
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
243
01:31Pulmonary Tuberculosis III
332
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
332
01:28Pulmonary Tuberculosis II
239
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
239
01:28Pneumonia IV: Management
329
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
329